Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington.
| Revenue (Most Recent Fiscal Year) | $0.07M |
| Net Income (Most Recent Fiscal Year) | $-3.07M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 255.96 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -3636.36% |
| Net Margin (Trailing 12 Months) | -3637.37% |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -144.13% |
| Current Ratio (Most Recent Fiscal Quarter) | 48.85 |
| Quick Ratio (Most Recent Fiscal Quarter) | 47.72 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 2.14 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-0.01 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.01 |
| Exchange | -- |
| Sector | -- |
| Industry | -- |
| Common Shares Outstanding | 493.96M |
| Free Float | 402.58M |
| Market Capitalization | $25.34M |
| Average Volume (Last 20 Days) | 0.95M |
| Beta (Past 60 Months) | -0.72 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 18.50% |
| Percentage Held By Institutions (Latest 13F Reports) | 0.00% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |